About Us
Company Profile
Executive Management
Board of Directors
Clinical Advisory Board
Our Pipeline
Our Science
For Patients
Investors & Media
Overview
News & Press Releases
Presentations
Publications
Events
SEC Filings
Stock Quote & Chart
Executive Management
Board of Directors
Board Committees
Corporate Governance
Clinical Advisory Board
Analyst Coverage
RSS Feeds
Contact Us
Contact Us
About Us
Company Profile
Executive Management
Board of Directors
Clinical Advisory Board
Our Pipeline
Our Science
For Patients
Investors & Media
Overview
News & Press Releases
Presentations
Publications
Events
SEC Filings
Stock Quote & Chart
Executive Management
Board of Directors
Board Committees
Corporate Governance
Clinical Advisory Board
Analyst Coverage
RSS Feeds
Contact Us
Contact Us
Home
>
News
All
|
News
|
Press Release
|
Events
Convalescent Serum Lines Up As First-Choice Treatment For Coronavirus
May 1, 2020
Jodi’s Journal: The Little Biotech Company That Could Beat COVID-19
April 26, 2020
Behind SAB’s Rapid Response To COVID-19
April 24, 2020
HHS Facilitates Development Of Immunotherapies For COVID-19 Patients
April 13, 2020
BARDA, Department Of Defense, And SAb Biotherapeutics To Partner To Develop A Novel COVID-19 Therapeutic
April 2, 2020
Sioux Falls Biotech Firm Rushing To Develop Coronavirus Treatment
March 12, 2020
Personal Impact, Global Influence, Right Here In South Dakota
February 18, 2020
South Dakota Leads The Future Of Fighting Disease
December 13, 2019
SAB Adds To Executive Team With Industry Veteran
November 12, 2019
S.D. Equity Partners Makes $1M Investment In SAB
December 19, 2018
Here’s What’s Next For Massive Biotech Project
October 11, 2017
Cows Engineered With Human Genes Could Stop Our Next Disease Outbreak
October 4, 2016
Previous
Next